Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 2c, Guidance Tops Views
February 26, 2024 4:10 PM ESTHims & Hers Health, Inc. (NYSE: HIMS) reported Q4 EPS of $, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $246.6 million versus the consensus estimate of $245.82 million.
GUIDANCE:
Hims & Hers Health, Inc. sees Q1 2024 revenue of $267-272... More
